Research analysts at StockNews.com initiated coverage on shares of Arch Biopartners (NYSE:ARCH – Get Free Report) in a note issued to investors on Wednesday. The brokerage set a “hold” rating on the stock.
Arch Biopartners Stock Performance
ARCH stock opened at $134.83 on Wednesday. Arch Biopartners has a 52 week low of $116.44 and a 52 week high of $180.65.
Further Reading
- Five stocks we like better than Arch Biopartners
- Financial Services Stocks Investing
- Beware of BigBear.ai: Insiders Are Selling—Should You?
- How Technical Indicators Can Help You Find Oversold Stocks
- CrowdStrike Stock is a Buy as Cyberthreat Environment Expands
- What is a Low P/E Ratio and What Does it Tell Investors?
- Congress! Who Traded What During the Tariff-Induced Meltdown
Receive News & Ratings for Arch Biopartners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arch Biopartners and related companies with MarketBeat.com's FREE daily email newsletter.
